Page last updated: 2024-08-26

arsenic and Idiopathic Parkinson Disease

arsenic has been researched along with Idiopathic Parkinson Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Blackburn, AC; Board, PG; Cavanaugh, JA; Masoumi, A; Schmuck, EM; Tetlow, N; Whitbread, AK1
Abraham, KS; Ayyadurai, N; G, S; Giridharan, B; Gopalakrishnan, AV; Kumar, N; Mahalaxmi, I; Nachimuthu, SK; Narayanasamy, A; P, S; Pasha, MY; Rao, KRSS; Reddy, JK; Selvaraj, P; Suriyanarayanan, A; Vellingiri, B; Venkatesan, D; Winster, H1
Khudoerkov, RM; Salkov, VN; Voronkov, DN1
Lee, CP; Su, CC; Zhu, CH1
Ascherio, A; Fitzgerald, K; Hart, JE; Laden, F; Palacios, N; Roberts, AL; Schwarzschild, MA; Weisskopf, MG1
Camenisch, TD; Cholanians, AB; Ditzel, EJ; Lau, SS; Monks, TJ; Phan, AV1
Damsgaard, E; Heydorn, K; Larsen, NA; Pakkenberg, H; Wold, S1

Reviews

2 review(s) available for arsenic and Idiopathic Parkinson Disease

ArticleYear
Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity.
    Chemosphere, 2022, Volume: 301

    Topics: Arsenic; Cadmium; Copper; Humans; Iron; Lithium; Metals, Heavy; Neurotoxicity Syndromes; Parkinson Disease

2022
[The role of mercury and arsenic in the etiology and pathogenesis of Parkinson's and Alzheimer's diseases].
    Arkhiv patologii, 2022, Volume: 84, Issue:5

    Topics: Alzheimer Disease; Antioxidants; Arsenic; Humans; Mercury; Neurodegenerative Diseases; Oxygen; Parkinson Disease

2022

Other Studies

5 other study(ies) available for arsenic and Idiopathic Parkinson Disease

ArticleYear
Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases.
    Pharmacogenetics and genomics, 2005, Volume: 15, Issue:7

    Topics: Age of Onset; Alzheimer Disease; Amino Acid Substitution; Arsenicals; Dehydroascorbic Acid; Genotype; Glutaredoxins; Glutathione Transferase; Hot Temperature; Humans; Oxidoreductases; Parkinson Disease; Polymorphism, Genetic; Protein Disulfide Reductase (Glutathione); Protein Folding; Sequence Deletion; Substrate Specificity

2005
Increased prevalence of Parkinson's disease in soils with high arsenic levels.
    Parkinsonism & related disorders, 2021, Volume: 88

    Topics: Adult; Aged; Aged, 80 and over; Arsenic; Arsenic Poisoning; Farms; Female; Geographic Mapping; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pesticides; Prevalence; Soil; Taiwan

2021
A prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses' health study cohort.
    Environmental health perspectives, 2014, Volume: 122, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Arsenic; Cohort Studies; Environmental Exposure; Female; Humans; Incidence; Metals, Heavy; Middle Aged; Parkinson Disease; Prospective Studies; United States

2014
From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and Neurodegeneration.
    Toxicological sciences : an official journal of the Society of Toxicology, 2016, Volume: 153, Issue:2

    Topics: alpha-Synuclein; Animals; Arsenic; Cell Line; Female; Mice; Neurodegenerative Diseases; Parkinson Disease

2016
Distribution of arsenic, manganese, and selenium in the human brain in chronic renal insufficiency, Parkinson's disease, and amyotrophic lateral sclerosis.
    Journal of the neurological sciences, 1981, Volume: 51, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Arsenic; Brain; Female; Humans; Kidney Failure, Chronic; Male; Manganese; Middle Aged; Parkinson Disease; Selenium

1981